Tender Details
Ref No 25939166
Document

Tender Notice

Bidding

Not specified

Short Description

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Nintedanib (Vargatef And Generics), Atc L01Ex09 For The Period 05/01/26-04/30/28 (Plus V. Option 1X12 Months)
Deadline *
Date 05 Mar 2029
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Germany
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 5976401
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

  • Deadline: 10 May 2026
  • Ref No: 5965319
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine As An Otc Medi

  • Deadline: 10 May 2026
  • Ref No: 5968352
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage

  • Deadline: 10 May 2026
  • Ref No: 8271966
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ciprofloxacin Oht Atr

  • Deadline: 10 May 2026
  • Ref No: 8280171
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Prednisolone Atr

  • Deadline: 10 May 2026
  • Ref No: 8281472
  • Location: Denmark

Qualification Scheme Technical Advice

  • Deadline: 28 Aug 2034
  • Ref No: 8296308
  • Location: Bulgaria

Sdp Supply Of Medicinal Products

  • Deadline: 31 Aug 2027
  • Ref No: 6590432
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pilocarpine

  • Deadline: 10 May 2026
  • Ref No: 4141456
  • Location: Lithunia

Procurement Of Services For The Preparation Of The Esg Strategy For The Preparation Of The Sustainability Report And The Creation Of The Plan For Its

  • Deadline: 02 Apr 2029
  • Ref No: 6591981
  • Location: Bulgaria

Delivery Of Medicinal Products For The Needs Of The Medical Center Dr Bratan Shukerov Jsc

  • Deadline: 24 Jun 2027
  • Ref No: 6594000
  • Location: Bulgaria

Delivery Of Medicinal Products For The Needs Of The Medical Center Dr Bratan Shukerov Jsc

  • Deadline: 24 Jun 2027
WhatsApp Chat